HPV Vaccination Recommendations Updated
Guidelines on vaccination for Human Papillomavirus Disease (HPV) for people living with HIV have been updated. (HPV is a major risk factor for the development of cervical cancer.) The revisions are in the HPV section of the HHS Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV Infected Adults and Adolescents and are presented by AIDSInfo in brief and full version formats, per the new presentation style for all HIV Guidelines on the AIDSInfo site.
The HPV update summarized in What's New:
"The Panel updated the recommendation on HPV vaccination in females and males with HIV infection ages 13 to 26 years to the 9-valent HPV recombinant vaccine (0.5 ml at 0, 1 to 2, and 6 months) (AIII). For patients who have completed a vaccination series with the recombinant bivalent or quadrivalent vaccines, many experts would give an additional full series of the 9-valent recombinant vaccine (CIII)."